Calendar Dova Pharmaceuticals, Inc.

Equities

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-0.07%	+269.92%

2019	Dova Pharmaceuticals Presents Additional Analyses from the Phase 3 Study - Core and Extension Phase - with Avatrombopag	CI
2019	Dova Pharmaceuticals Presents Additional Analyses from the Phase 3 Study Core and Extension Phase	CI

38b073.JbC_Q-Wgp2auWENUw-4Y-Euv3t8RUGP7wDl_wZEvd4k.atPPdZ_y-CmDEwkwob9etz7_kJZGaVCioVQN8cR3BMpNwuhw1urXNeguEg~9ca0d27431a58adb07858c257ac20c56

No events available

12/11/2019 10:15 pm	Credit Suisse Healthcare Conference
03/10/2019 01:40 am	Cantor Global Health Care Conference
25/09/2019 12:00 am	Ladenburg Thalmann Health Care Conference
24/09/2019	Investor Meeting
09/09/2019 10:00 pm	H.C. Wainwright Global Investor Conference
14/08/2019 12:00 am	Wedbush PacGrow Healthcare Conference
06/08/2019 06:30 pm	Interim 2019 Earnings Call
06/08/2019 04:30 pm	Interim 2019 Earnings Release
07/07/2019 02:00 pm	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0399
07/07/2019 02:00 pm	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0418
07/07/2019 02:00 pm	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0417
07/07/2019 02:00 pm	International Society on Thrombosis and Haemostasis Scientific Meeting - Abstract PB0416
27/06/2019 06:30 pm	DOPTELET FDA Approval Call
04/06/2019 08:30 pm	Jefferies Healthcare Conference
20/05/2019 11:30 pm	UBS Global Healthcare Conference
07/05/2019 06:30 pm	Q1 2019 Earnings Call
07/05/2019	Q1 2019 Earnings Release
26/04/2019	Annual General Meeting
09/04/2019 02:00 pm	H. C. Wainwright Global Life Sciences Conference
05/03/2019 07:30 pm	FY 2018 Earnings Call

Fiscal Period	December	2017	2018
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	10,4 10,3 0.4%
EBITDA Million USD	Released Forecast Spread	-29,2 -29,0 -0.72%	-71,0 -73,4 3.25%
EBIT Million USD	Released Forecast Spread	-29,2 -29,0 -0.72%	-71,1 -73,3 3.13%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-30,0 -29,0 -3.29%	-72,3 -74,8 3.4%
Net income Million USD	Released Forecast Spread	-30,0 -29,0 -3.29%	-72,3 -74,8 3.4%
EPS USD	Released Forecast Spread	-1,40 -1,46 3.78%	-2,60 -2,68 3.13%
Announcement Date		15/02/18	05/03/19

24/07/2024	VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024	BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am	ARGENX SE: Q2 2024 Earnings Release
30/07/2024	RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024	CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024	CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024	SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024	XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024	SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)

05/06/2024 01:21 pm	PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm	AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm	BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am	ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024	LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm	THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm	CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024	TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am	ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am	ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release